MedTrace Logo

The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction

NCT04564365 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-11-11

No results posted yet for this study

Summary

The use of beta blockers after acute myocardial infarction is a core component of drug therapy, but evidence is primarily derived from patients who did not receive reperfusion therapy and secondary prophylaxis.In contemporary times, the prognostic value of beta blockers in patients with acute myocardial infarction has been questioned, particularly in patients without reduced heart failure/ejection fraction after acute myocardial infarction.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

beta-blocker

To investigate the relationship between the use of beta blockers and prognosis in patients with normal ejection fraction after acute myocardial infarction

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2021-11-25
Completion
2021-12-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04564365 on ClinicalTrials.gov